Clinical trial
Pramipexole Conversion to Ropinirole Controlled Release (CR)
NCT00275275 · Rajesh Pahwa, MD, Other · Completed
Key facts
| NCT number | NCT00275275 |
|---|---|
| Title | Pramipexole Conversion to Ropinirole Controlled Release (CR) |
| Official title | An Open Label Conversion Study of Pramipexole to Ropinirole Controlled Release (CR) in Patients With Parkinson's Disease. |
| Lead sponsor | Rajesh Pahwa, MD, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | Requip PR, Mirapex |
| Enrollment | 61 |
| Start date | Jan 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Jan 11, 2006 |
| Last update posted | Aug 24, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: